Bioinformatic clonality analysis of next-generation sequencing-derived viral vector integration sites.

Clonality analysis of viral vector-transduced cell populations represents a convincing approach to dissect the physiology of tissue and organ regeneration, to monitor the fate of individual gene-corrected cells in vivo, and to assess vector biosafety. With the decoding of mammalian genomes and the introduction of next-generation sequencing technologies, the demand for automated bioinformatic analysis tools that can rapidly process and annotate vector integration sites is rising. Here, we provide a publicly accessible, graphical user interface-guided automated bioinformatic high-throughput integration site analysis pipeline. Its performance and key features are illustrated on pyrosequenced linear amplification-mediated PCR products derived from one patient previously enrolled in the first lentiviral vector clinical gene therapy study. Analysis includes trimming of vector genome junctions, alignment of genomic sequence fragments to the host genome for the identification of integration sites, and the annotation of nearby genomic elements. Most importantly, clinically relevant features comprise the determination of identical integration sites with respect to different time points or cell lineages, as well as the retrieval of the most prominent cell clones and common integration sites. The resulting output is summarized in tables within a convenient spreadsheet and can be further processed by researchers without profound bioinformatic knowledge.

[1]  F. Bushman,et al.  Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences , 2004, PLoS biology.

[2]  Tatiana A. Tatusova,et al.  NCBI Reference Sequences: current status, policy and new initiatives , 2008, Nucleic Acids Res..

[3]  Sean D. Mooney,et al.  Identifying viral integration sites using SeqMap 2.0 , 2011, Bioinform..

[4]  Alessandro Aiuti,et al.  Gene therapy for immunodeficiency due to adenosine deaminase deficiency. , 2009, The New England journal of medicine.

[5]  Paul Shinn,et al.  HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots , 2002, Cell.

[6]  Abdul Hakkim,et al.  Restoration of NET formation by gene therapy in CGD controls aspergillosis. , 2009, Blood.

[7]  Shawn M. Burgess,et al.  Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration , 2003, Science.

[8]  Christof von Kalle,et al.  Analyzing the Number of Common Integration Sites of Viral Vectors – New Methods and Computer Programs , 2011, PloS one.

[9]  A. Mortellaro,et al.  Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative Conditioning , 2002, Science.

[10]  J. Silver,et al.  Novel use of polymerase chain reaction to amplify cellular DNA adjacent to an integrated provirus , 1989, Journal of virology.

[11]  W. J. Kent,et al.  BLAT--the BLAST-like alignment tool. , 2002, Genome research.

[12]  C. von Kalle,et al.  Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trial. , 2005, Blood.

[13]  F. Bushman,et al.  Is normal hematopoiesis maintained solely by long-term multipotent stem cells? , 2011, Blood.

[14]  G Opelz,et al.  QuickMap: a public tool for large-scale gene therapy vector insertion site mapping and analysis , 2009, Gene Therapy.

[15]  J. Tisdale,et al.  Chicken HS4 insulators have minimal barrier function among progeny of human hematopoietic cells transduced with an HIV1-based lentiviral vector. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[16]  Terrence S. Furey,et al.  The UCSC Table Browser data retrieval tool , 2004, Nucleic Acids Res..

[17]  I. Lemischka,et al.  The return of clonal marking sheds new light on human hematopoietic stem cells , 2001, Nature Immunology.

[18]  F. Bushman,et al.  The host genomic environment of the provirus determines the abundance of HTLV-1–infected T-cell clones , 2011, Blood.

[19]  Hans Martin,et al.  Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease , 2010, Nature Medicine.

[20]  James R. Knight,et al.  Genome sequencing in microfabricated high-density picolitre reactors , 2005, Nature.

[21]  Manfred Schmidt,et al.  Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy , 2009, Science.

[22]  Christof von Kalle,et al.  Stem-cell gene therapy for the Wiskott-Aldrich syndrome. , 2010, The New England journal of medicine.

[23]  Hanno Glimm,et al.  High-resolution insertion-site analysis by linear amplification–mediated PCR (LAM-PCR) , 2007, Nature Methods.

[24]  Frederic D. Bushman,et al.  Efficacy of gene therapy for X-linked severe combined immunodeficiency. , 2010, The New England journal of medicine.

[25]  Stephan Wolf,et al.  Genome-wide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing , 2010, Nature Protocols.

[26]  Yang Du,et al.  Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1 , 2006, Nature Medicine.

[27]  Jeffrey C. Miller,et al.  An unbiased genome-wide analysis of zinc-finger nuclease specificity , 2011, Nature Biotechnology.

[28]  M. Lardelli,et al.  A hyperactive sleeping beauty transposase enhances transgenesis in zebrafish embryos , 2010, BMC Research Notes.

[29]  N. Copeland,et al.  Harnessing transposons for cancer gene discovery , 2010, Nature Reviews Cancer.

[30]  C. von Kalle,et al.  Efficient marking of human cells with rapid but transient repopulating activity in autografted recipients. , 2005, Blood.

[31]  Rafael J. Yáñez-Muñoz,et al.  Lentiviral vector integration profiles differ in rodent postmitotic tissues. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[32]  A. Fischer,et al.  Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. , 2002, The New England journal of medicine.

[33]  C. von Kalle,et al.  Real-Time Definition of Non-Randomness in the Distribution of Genomic Events , 2007, PloS one.

[34]  M. Koch,et al.  Distinct types of tumor-initiating cells form human colon cancer tumors and metastases. , 2011, Cell stem cell.

[35]  Cameron S. Osborne,et al.  LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 , 2003, Science.

[36]  Christine Kinnon,et al.  Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. , 2008, The Journal of clinical investigation.

[37]  Takeshi Suzuki,et al.  New genes involved in cancer identified by retroviral tagging , 2002, Nature Genetics.

[38]  Luca Biasco,et al.  Comprehensive genomic access to vector integration in clinical gene therapy , 2009, Nature Medicine.

[39]  M. Dinauer,et al.  Gene therapy of chronic granulomatous disease: the engraftment dilemma. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[40]  Jérôme Larghero,et al.  Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia , 2010, Nature.

[41]  B. Wold,et al.  In vivo footprinting of a muscle specific enhancer by ligation mediated PCR. , 1990, Science.

[42]  C. von Kalle,et al.  Retroviral gene therapy for X-linked chronic granulomatous disease: results from phase I/II trial. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[43]  F. Bushman,et al.  Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. , 2008, The Journal of clinical investigation.

[44]  C. von Kalle,et al.  Hepatocyte-Targeted Expression by Integrase-Defective Lentiviral Vectors Induces Antigen-Specific Tolerance in Mice with Low Genotoxic Risk , 2011, Hepatology.

[45]  Feng Chen,et al.  Sequencing and Analysis of Neanderthal Genomic DNA , 2006, Science.

[46]  Gianluigi Zanetti,et al.  Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection. , 2011, Blood.

[47]  Christine Kinnon,et al.  Mutations in TNFRSF13B Encoding TACI Are Associated With Common Variable Immunodeficiency in Humans , 2006, Pediatrics.